JUL 16, 2019 5:14 AM PDT

Lipid Nanoparticles Improve the Delivery of CRISPR/Cas9 Into Cells

WRITTEN BY: Carmen Leitch

The CRISPR/Cas9 gene-editing tool has revolutionized biomedical research and has tremendous potential for use in the clinic. There are still many challenges that need to be addressed before it’s safe for people, however. A team of scientists from Tufts University and the Chinese Academy of Sciences has now improved the way CRISPR/Cas9 tools are delivered to cells where they’re supposed to make the intended edits. This approach utilizes synthetic and biodegradable lipid nanoparticles, which deliver reagents that make the edits with about 90 percent efficiency. The nanoparticles, reported in Advanced Materials, can help scientists create a tool that is useful in the clinic as a therapeutic.

One problem with CRISPR/Cas9, which is described in the video, is its size. It requires an enzyme called a nuclease that cuts the genome, in this case, it’s Cas9, as well as a specific RNA molecule that can guide the nuclease to the precise point in the genome where the cut should be made. The genome is located in the nucleus of the cell, and the size of the CRISPR/Cas9 tool can prohibit it from entering. Scientists have tried packaging it into viruses, polymers, or other kinds of nanoparticles with limited success.

In this work, the researchers turned to lipid nanoparticles to carry messenger RNA encoding for the Cas9 nuclease, which is translated when it enters a cell, instead of the nuclease itself. The synthetic lipids composing the nanoparticles contain disulfide bonds, which break open when it gets inside of a cell; the contents of the nanoparticles then get rapidly released there.

"We are just starting to see human clinical trials for CRISPR therapies," said Qiaobing Xu, co-corresponding author of the study and associate professor of biomedical engineering at Tufts University. "There are many diseases that have long been intractable for which CRISPR therapies could offer new hope - for example, sickle cell disease, Duchenne muscular dystrophy, Huntington's disease, and even many cancers. Our hope is that this advance will take us another step toward making CRISPR an effective and practical approach to treatment."

Lipids formulated with a bioreducible linker form the wall of nanoparticles encapsulating Cas9 mRNA and sgRNA. Linkers are broken upon entering cell in vitro or in vivo, the particles disintegrate, contents are delivered and used by the cell. / Credit: Qiaobing Xu, Tufts University

The scientists tested their technique with a mouse model. They aimed to lower the levels of a gene encoding for PCSK9. Lower levels of this protein have been linked to a reduction in LDL cholesterol levels, which lowers the risk of cardiovascular disease.

"The lipid nanoparticles are one of the most efficient CRISPR/Cas9 carriers we have seen," said co-corresponding study author Ming Wang, a professor at the Chinese Academy of Sciences, Beijing National Laboratory for Molecular Science. "We can actually knock down PCSK9 expression in mice with 80 percent efficiency in the liver, suggesting a real promise for therapeutic applications."


Sources: AAAS/Eurekalert! via Tufts University, Advanced Materials

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 07, 2020
Genetics & Genomics
MAR 07, 2020
Learning Why Men Tend to Die Younger
Data has shown conclusively that even though women tend to have poorer health than men during their adult lives, they li ...
MAR 15, 2020
Genetics & Genomics
MAR 15, 2020
Insight Into Neuronal Growth and Memory Formation
Now scientists have learned more about the transport of mRNA in neurons, and the storage and formation of memories.
APR 01, 2020
Microbiology
APR 01, 2020
How Two Types of Tests for COVID-19 Work
There are a couple of different kinds of tests that researchers will be developing and clinicians will be using to disru ...
MAY 03, 2020
Genetics & Genomics
MAY 03, 2020
Conspiracy Theories Surrounding the Origins of SARS-CoV-2
The origin of SARS-CoV-2, the pandemic virus that causes COVID-19, has become politicized as leaders seek to place blame ...
MAY 10, 2020
Genetics & Genomics
MAY 10, 2020
Towards a Targeted Elimination of Leukemic Cells
Our blood carries many types of critical cells, including platelets, red blood cells, and white blood cells, which are m ...
JUN 01, 2020
Microbiology
JUN 01, 2020
The Most Common Marine Microbe Has a Virus in Its Genome
Single-celled ocean microbes known as Pelagibacter or SAR11 make up about 25 percent of the plankton on the planet.
Loading Comments...